ArticleCellular oncology (Dordrecht, Netherlands)2025

Lenvatinib-activated NDUFA4L2/IL33/PADI4 pathway induces neutrophil extracellular traps that inhibit cuproptosis in hepatocellular carcinoma.

Nan Yi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.